CYP2D6 poor metabolizer status might be associated with better response to risperidone treatment

  1. Almoguera, B.
  2. Riveiro-Alvarez, R.
  3. Lopez-Castroman, J.
  4. Dorado, P.
  5. Vaquero-Lorenzo, C.
  6. Fernandez-Piqueras, J.
  7. Llerena, A.
  8. Abad-Santos, F.
  9. Baca-García, E.
  10. Dal-Ré, R.
  11. Ayuso, C.
Journal:
Pharmacogenetics and Genomics

ISSN: 1744-6872 1744-6880

Year of publication: 2013

Volume: 23

Issue: 11

Pages: 627-630

Type: Article

DOI: 10.1097/FPC.0B013E3283659A94 GOOGLE SCHOLAR

Sustainable development goals